According to WuXi Biologics's latest financial reports the company's current revenue (TTM ) is NZ$3.91 Billion. In 2022 the company made a revenue of NZ$3.91 Billion an increase over the revenue in the year 2021 that were of NZ$2.85 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.